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Abstract
Background: Obesity is a major public health problem. Body mass index (BMI) is a highly heritable
phenotype but robust associations of genetic polymorphisms to BMI or other obesity-related
phenotypes have been difficult to establish. Recently a large genetic association study showed
evidence for association of the single nucleotide polymorphism (SNP) rs7566605, which lies 10 Kb
5' to the first exon of the insulin-induced gene 2 (INSIG-2), with obesity in several cohorts. We
tested this polymorphism for association with body mass related phenotypes in a large family study
whose mean BMI was consistent with moderate overweight.
Methods: We studied 1428 members of 248 British Caucasian families who had been ascertained
through a proband with hypertension. We measured BMI, waist and hip circumference, and plasma
levels of leptin. We genotyped the rs7566605 SNP using a restriction fragment length
polymorphism assay, and carried out a family-based association test for quantitative traits related
to obesity using the statistical programs MERLIN and QTDT.
Results: We observed no significant association between genotype at rs7566605 and covariate-
adjusted (for age, sex, alcohol consumption, smoking and exercise habit) log-transformed BMI,
waist measurement, hip measurement, waist-to-hip ratio, or plasma levels of leptin.
Conclusion: There was no association between genotype at rs7566605 and obesity-related
phenotypes in this British Caucasian population. These families were in general moderately
overweight, few members being severely obese. Our result indicates that this polymorphism has
little if any effect on BMI within the normal to moderately overweight range. The effects of this
polymorphism on body mass may be restricted to those already predisposed to at least moderate
obesity as a result of environmental factors and other predisposing genotypes.
Background
Obesity is an increasingly prevalent public health prob-
lem worldwide [1]. Obesity is a major risk factor for the
development of hypertension, diabetes, coronary heart
disease and stroke [2]. Secular trends towards overweight
indicate the strong influence of lifestyle on the risk of
obesity; nevertheless multiple studies assessing heritabil-
ity within families have shown evidence for significant
genetic influences on body mass index [3,4]. Identifica-
tion of these genetic determinants has thus far proved dif-
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following a genome-wide association study involving
86,604 SNPs, one SNP (rs7566605) situated 10 Kb 5' to
the insulin-induced gene 2 (INSIG-2) which showed
strong evidence for association with body mass index in
multiple cohorts (OR for obesity 1.22 [95% CI 1.05–
1.42]; p = 0.008 in meta-analysis of 6 cohorts). Homozy-
gotes for the minor C allele (around 10% of the popula-
tion) had BMI about 1 Kg/m2 higher than did
homozygotes for the major G allele or GC heterozygotes
[5]. That study tended to show the strongest evidence for
association in cohorts selected for severe obesity; in one of
the cohorts tested (the Nurses' Health Study cohort)
whose mean BMI was more representative of the majority
of overweight patients there was no association between
the SNP and obesity. Obesity is a major risk factor for
hypertension, but most hypertensives are moderately,
rather than severely overweight [6]. We therefore tested
the association of rs7566605 with body mass index in a
large family collection, selected through a proband with
hypertension, which we have previously used successfully
to identify SNPs associated with obesity related pheno-
types.
Methods
Subject collection and phenotyping
The collection strategy of this family study has been previ-
ously described [7]. Briefly, families were ascertained
through a proband with essential hypertension. In order
to be suitable for the study, families were required to con-
sist of at least three siblings clinically assessable for blood
pressure if at least one parent of the sibship was available
to give blood for DNA analysis, and to consist of at least
four assessable siblings if no parent was available. Where
members of the sibship were found to be hypertensive,
families were extended and the spouses and offspring of
hypertensive sibs collected. Thus, the majority of the indi-
viduals in the family collection have blood pressures
within the normal range, and the family collection
includes some extended families, though most are nuclear
families. A full medical and lifestyle history was taken.
Subjects underwent automated ambulatory blood pres-
sure monitoring for 24 hours (A&D TM2421 monitor)
with readings taken half-hourly by day and hourly by
night. Anthropometric measurements including height,
weight, and waist and hip circumferences were made
(waist measured at the natural waist, and hip measured at
the level of the greater trochanters). Body mass index was
calculated as the weight (in Kg) divided by the square of
height (in m). 1428 individuals from 248 families partic-
ipated in the study. The study was approved by the appro-
priate local Ethics Committee. All participants gave
informed consent to participate in the study.
Laboratory methods
Plasma leptin was measured using a commercially availa-
ble ELISA kit (Linco Research, St. Charles, MO) with sen-
sitivity 0.5 ng/ml, intra-assay precision 2.6–4.6% and
inter-assay precision 2.6–6.2%. The rs7566605 SNP was
genotyped by PCR using forward and reverse primers 5'-
CCC TCC AAT ACC CCA TCG GA-3' and 5'-GGG AAT
CGA GAG CTA AGG AT-3', respectively. Each 15 μl PCR
reaction mixture consisted of 25 ng genomic DNA, 0.2 μM
of each primer, 0.2 mM dNTPs, 2.5 mM MgCl2, 1 × Hot-
StarTaq reaction buffer, and 0.2 units of HotStarTaq DNA
polymerase (QIAGEN, Crawley, UK). The amplification
procedure consisted of initial denaturation at 95°C for 15
min, 40 cycles of denaturation at 95°C for 20 s, annealing
at 52°C for 30 s, and extension at 72°C for 1 min, fol-
lowed by a final extension at 72°C for 3 min. The 182 bp
PCR amplicon was digested with Mbo I restriction enzyme
(Promega, Madison, USA). The 20 μl reaction volumes
contained 4 μl PCR product, 1 × reaction buffer C, 0.1 mg/
ml Acetylated BSA, 2 units Mbo I. Digests were carried out
at 37°C for 15 hours to ensure complete digestion of the
PCR product. Fragments were separated by electrophore-
sis on 3% agarose gels. There is no Mbo I restriction site in
the G allele amplicon, yielding a band of 182 bp. The C
allele amplicon has one Mbo I restriction site, resulting in
two restriction fragments of 67 bp and 115 bp. Reference
individuals of known genotype were included in every
run. 10% of samples were re-genotyped and no discord-
ance between genotype calls was observed, yielding an
estimated genotyping error rate of <1%. Genotypes were
successfully scored on over 95% of individuals with DNA
available.
Statistical analysis
Phenotypes of interest were examined for Normality and
log-transformed in the case of body mass index (BMI) and
plasma leptin to achieve an approximately Normal distri-
bution. The distribution of waist-hip ratio did not depart
significantly from Normality. Significant covariates of
these phenotypes were then determined by linear regres-
sion using MINITAB; the adjusted values from these
regressions were standardised (so each phenotype has a
mean of zero and a standard deviation of 1) and used in
the genetic analyses. The covariates age, sex, smoking
(graded current/former/never), presence of cardiovascular
medications, alcohol consumption (in units per week),
exercise habit (graded none regular/1 or 2 times per week/
three or more times per week) were considered. Mende-
lian inheritance of all genotypes and correspondence of
genotype frequencies to Hardy-Weinberg proportions was
checked using PEDSTATS [8]. Association between geno-
types and the adjusted phenotypes was assessed in the
families by calculating identity-by-descent vectors for
each individual using MERLIN [9] followed by variance
components analysis considering BMI and waist-hip ratioPage 2 of 6
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rated a dominance parameter since the original observa-
tion had been a recessive effect of the C allele. We also
carried out TDT analyses in which those individuals with
age- and sex-adjusted BMI >30 (N = 206) were designated
affected and those with BMI < 25 (N = 733) unaffected,
those with BMI between 25 and 30 being designated
unknown.
Results
Characteristics of the study subjects are shown in Table 1.
60% of families comprised between 4 and 6 genotyped
members. Median values for BMI, WHR and plasma lep-
tin lie towards the upper end of the normal range for an
unselected UK Caucasian population [11], while daytime
systolic and diastolic blood pressures would be consistent
with selection of these families through a hypertensive
proband. Correction for age, sex, alcohol consumption,
smoking and habitual exercise accounted for about 15%
of the total variability in log BMI, and 46–49% of the total
variability in WHR and log plasma leptin level. The herit-
ability of the obesity phenotypes after correction was 35%
for log BMI, 28% for WHR and 36% for log plasma leptin
(all p < 0.0001).
Genotype frequencies at rs7566605 were in correspond-
ence with Hardy-Weinberg proportions (p > 0.1). The fre-
quency of the G allele in this population was 0.69 and of
the C allele 0.31, which is in good agreement with the
Caucasian populations genotyped in the study by Herbert
et al [5]. The polymorphism had 40% heterozygosity. The
mean values of BMI, waist-hip ratio and plasma leptin in
each of the three genotype groups are shown in Table 2.
There was no significant association between genotype
and covariate-adjusted, log-transformed BMI measured as
a continuous variable either under the recessive model
(CC versus GG and GC; p > 0.10) found to be significant
in the study by Herbert et al., under a codominant model
(CC versus CG versus GG; p > 0.10), or under a dominant
model (CC and CG versus GG; p > 0.10). Neither was
there evidence of association between genotype and obes-
ity affection status (defined as BMI > 30, with control sta-
tus BMI < 25) under any model. There was no significant
association between genotype and the obesity-related
phenotypes WHR or log plasma leptin level as continuous
variables (p > 0.1 for all comparisons; Figure 1).
Discussion
This study of 1428 individuals from 248 families with
median BMI 25.4 (indicating that about half the cohort
were overweight) did not show any association between
the CC genotype of the rs7566605 SNP, situated some 10
Kb 5' to the INSIG-2 gene, and body mass index, waist-hip
ratio, or plasma leptin levels as quantitative traits. Nor
was there any association between genotype and obesity
when considered as an affection status, although our
study contained relatively few such individuals. These
results suggest that the effect of the rs7566605 SNP on
BMI within the range encompassing normal and over-
weight is at most small, despite the evidence from a previ-
ous study that the CC genotype at this SNP may be a
significant risk factor for obesity (classified as BMI > 30)
[5].
It is possible that this study did not have sufficient power
to replicate the association described by Herbert et al. The
"winner's curse" phenomenon has been invoked to
explain the frequently observed phenomenon in genetic
epidemiology that first studies reporting a novel associa-
tion very frequently show more extreme odds ratios than
subsequent replication studies [12]. If the estimated OR
for obesity of 1.22 in the study by Herbert et al. is in fact
an upwardly biased estimate of the true association, this
might explain our negative result. Also, families in the
present study were not selected for obesity, which would
tend to decrease their power to replicate the association.
However, the present family collection has previously
detected quantitative genetic effects contributing less than
5% of the total population variability in several traits
(including obesity-related phenotypes) for which the fam-
ilies were not selected; these associations have themselves
been replicated in other studies [13-19]. Moreover, the
original test cohort showing a significant association
(from the Framingham Heart Study) in the paper by Her-
Table 1: Characteristics of the study population
Variable n min LQ median UQ max R2†
Age (yr) 1425* 18.7 35.7 50.9 60.9 90.7 -
BMI (kg/m2) 1402 16.7 23.1 25.4 28.2 51.8 15.2
WHR 1357 0.56 0.78 0.85 0.91 1.22 48.7
Plasma Leptin (ng/μl) 1319 1.1 4.6 8.6 15.3 116.6 46.4
Daytime systolic BP (mmHg) 958 94.2 121.1 131 144.1 214.0 20.4
Daytime diastolic BP (mmHg) 958 54.0 72.0 78.6 88.0 119.9 17.9
* of which 52.4% were female and 36.1% were classified as hypertensive.
† After correction for age, sex, alcohol consumption, smoking behaviour, and exercise habit.
LQ = lower quartile, UQ = upper quartilePage 3 of 6
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tribution was similar to that in the present study – and
that Framingham cohort was smaller than the present
study. Lack of power is therefore an unlikely explanation
for non-replication.
The families in the present study were selected through a
hypertensive proband; selection bias could in theory be
the reason for non-replication. However, since we did not
select against overweight, since hypertension is not
thought to directly cause obesity, and since two-thirds of
the family members were non-hypertensive, this seems
unlikely. We only typed the rs7566605 SNP in these anal-
yses. If the previously observed association arose through
linkage disequilibrium (LD) between rs7566605 and a
neighbouring causative SNP, and if that LD between alle-
les at rs7566605 and that SNP were weaker in our popu-
lation than the populations studied by Herbert et al., that
Means and 95% CIs of adjusted standardised log BMI, waist-hip ratio and log Leptin grouped by rs7566605 genotypeFigure 1
Means and 95% CIs of adjusted standardised log BMI, waist-hip ratio and log Leptin grouped by rs7566605 genotype. Numbers 
in the three genotype groups are GG 689, GC 570, CC 113.
Table 2: Genotype-phenotype association at rs7566605
rs756605 genotype
G/G G/C C/C
N 689 570 113
BMI Kg/m2 26.132 (0.167) 25.944 (0.179) 25.626 (0.420)
Waist-hip ratio 0.853 (0.004) 0.858 (0.004) 0.848 (0.009)
Plasma Leptin ng/μL 12.53 (0.51) 11.92 (0.51) 12.70 (1.20)
Figures are means (standard errors)Page 4 of 6
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additional genotyping data at neighbouring SNPs, we can-
not entirely rule out this possibility. However, the families
studied here have previously shown very similar haplo-
type frequencies and LD patterns to other European Cau-
casian cohorts and HapMap data on Caucasian families at
multiple loci, so this also seems unlikely to explain our
negative findings.
Several of the populations tested by Herbert et al. had
been selected for extreme and/or childhood onset obesity
[5]. No association was observed in the 2726 participants
in the Nurses' Health Study cohort that were genotyped in
that report; members of that cohort had a significantly
lower mean BMI than the other populations studied,
although about half were overweight (median BMI 24.89;
IQR 22.35–28.43), as in the present study. Our findings,
considered together with the negative result in the Nurses'
Health Study cohort obtained by Herbert et al., suggest
that that the effects of the rs7566605 SNP on body mass
may be apparent only in individuals who are already pre-
disposed to significant obesity for other genetic and envi-
ronmental reasons. Such a notion would be in keeping
with what is known about the function of the INSIG-2
gene. Further studies in overweight populations will be
necessary to resolve this issue, and to detect such interact-
ing factors.
Conclusion
The majority of people at risk from atheromatous cardio-
vascular disease and diabetes have BMIs in the range 25–
30. The negative results of the present study pertain to
such a moderately overweight cohort who are at addi-
tional risk of cardiovascular disease by virtue of a familial
tendency to hypertension. They suggest that the public
health implications of the previously described genetic
association between the rs7566605 SNP and BMI may be
at most moderate.
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